Skip to main content

Better funding for GPs could reduce use of A & Departments by children

Children whose GPs are easy to access are less likely to visit A&E than those whose GPs are less able to provide appointments. These are the findings of a new study, led by researchers from Imperial College London, and published in the journal Pediatrics. The research also found that during weekdays, children’s visits to A&E peak after school hours.

The study, which was funded by the National Institute for Health Research, suggests that modest changes in the provision of GP appointments – such as providing more after-school appointments between the times of 5-7pm - could prevent thousands of visits to emergency departments a year. Although the study does not show that difficulty in accessing GP services is the direct cause behind increased emergency admissions, it raises important questions about the provision of GP services.

The study’s lead author, Dr Sonia Saxena, from the Department of Primary Care and Public Health at Imperial College London, and a practising GP, says: “Use of emergency departments for problems that could be dealt with in primary care is an inefficient use of the service, and could detract resources from more seriously ill children.  Our study was not a trial, which means that we don’t know whether difficulty accessing GPs is the cause of increased emergency department usage, or whether there is some other explanation for the link. However, given recent debates surrounding GP opening hours, our results suggest that additional resources to provide GP appointments for children when they need it - for instance after school rather than at weekends - may be a better investment for the NHS than blanket proposals to increase access hours.”

Comments

Popular posts from this blog

Improving discharge planning in NHS hospitals

Factors that need to be considered in discharge planning that have been identified in previous projects include:

Ensuring that discharge arrangements are discussed with patients, family members and carers; and that they are given a copy of the discharge summary.Adequate coordination between the hospital, community health services, general practices, and the providers of social care services.There is a follow-up after discharge of patients at high risk of complications or readmission - either in person or by telephone - to ensure that the discharge arrangements are working well. Medicines reconciliation is carried out. This is the process of verifying patient medication lists at a point-of-care transition, such as hospital discharge, to identify which medications have been added, discontinued, or changed from pre-admission medication lists.Ensuring that any outstanding test results at discharge are obtained and passed on to primary care teams; and ensuring there are clear arrangements …

Can GPs issue private prescriptions to NHS patients?

The NHS prescription charge in England is currently £8.40 per item. At this level, many commonly prescribed drugs will cost less than the prescription charge and so some NHS patients may occasionally ask if they can have a private prescription rather than an NHS prescription.

In the past, some GPs have been advised that they could issue both an NHS FP10 and a private prescription, and let the patient decide which to use. But the British Medical Association's General Practice Committee has obtained legal advice that said under the current primary care contract, GPs in England may not issue a private prescription alongside or as an alternative to an NHS FP10 prescription. In any consultation where a GP needs to issue an FP10, the concurrent issue of a private prescription would be a breach of NHS regulations.

The issuing of a private prescription in such circumstances could also be seen as an attempt to deprive the NHS of the funds it would receive from the prescription charge. Fur…

What impact will Brexit have on the UK's life sciences sector?

On Thursday 3 November 2016, I spoke at a seminar at the Imperial College Business School on the topic of the impact of Brexit on the UK's life sciences sector (the NHS, universities, and pharmaceutical and biomedical companies). I emphasised the important role played in the life sciences sector by EU-trained professionals and the need to ensure that the UK continued to attract highly-qualified professionals to work, for example, in our National Health Service. I also discussed the need to increase spending on research and development to ensure that the UK remained a world leader in the biomedical industry. The other speakers at the seminar were Andrew Lansley (former Secretary of State for Health) and Richard Phillips (Director of Healthcare Policy at the Association of British Healthcare industries). The event was chaired by Andrew Brown. A copy of my talk can be viewed on Slideshare.